Toggle menu

BRAINED Study

Start date:
April 2018
End date:
August 2020
Co-ordinated by:
Neurosurgery Department, Western General Hospital, Edinburgh
Main trial site:
RIE & Western General Hospital, Edinburgh

 

Blood samples will be assessed using infrared spectroscopy as part of a project looking at tumour biomarkers to ascertain whether people most at risk of having a brain tumour can be correctly identified.

This is a tissue governance project aiming to recruit 600 participants in order to inform a larger trial.

Chief Investigator

Mr Paul Brennan

Consultant Neurosurgeon

Local PI

Dr Matt Reed

Director of EMERGE, Consultant, NRS Career Research Fellow & Honorary Reader in Emergency Medicine

Research Team

Rachel O'Brien

Lead Research Nurse

Clare Moceivei

Research Nurse- Bank Staff

Allan MacRaild

Stroke Lead Research Nurse

Jessica Teasdale

Senior Research Nurse - Stroke/Neurosurgery

Michelle Coakley

Senior Research Nurse - Stroke/Neurosurgery

More EMERGE Trials

Diagnostics devices play an important part in the clinical assessment of a patient’s health and treatment. The purpose of the study is the evaluation of a new diagnostic platform developed by LumiraDx. The evaluation is focused around various biomarkers useful in the emergency settings.

Read more

NOVEL Study

Collection of venous and capillary blood samples for the evaluation of new diagnostic devices for cardiovascular conditions

DASH Trial

DASH is a randomised clinical trial investigating a treatment to reverse the effects of blood-thinning medications.